Utilisation : Ce produit est destiné uniquement à la recherche.
Toutes les informations sur les produits présentes sur ce site sont fournies à titre éducatif uniquement. Toute forme d’introduction dans le corps humain ou animal est strictement interdite par la loi. Ce produit doit être manipulé uniquement par des professionnels agréés et qualifiés. Il ne s’agit pas d’un médicament, d’un aliment ou d’un cosmétique et il ne doit pas être présenté, utilisé ou étiqueté comme tel.
Coluracetam – Powder, 1 gram
Pendant notre changement d’emballage, vous pouvez recevoir des produits avec l’ancienne ou la nouvelle étiquette. La formulation, la pureté et la qualité restent exactement les mêmes, selon nos standards.
- Carte de crédit
- Virement bancaire (SEPA instantané)
- Virement bancaire (ACH)
- Wise
- Revolut
- Zelle
- Remitly
- Western Union
- Chime
- Autres
-25% sur tout – jusqu’au 31 octobre
25% sur les prix habituels, en remplacement des autres soldes. Cumulable uniquement avec la remise crypto.
Expédition le jour même pour les commandes aux États-Unis passées avant 12 h EST.
Voir la politique de livraison →Chaque lot est testé pour sa pureté, sa puissance et sa qualité.
Voir les résultats d’analyse →Coluracetam (MKC-231) is a synthetic compound incorporating a tetrahydrofuroquinoline ring system fused to a pyrrolidinone-derived acetamide substituent, structurally related to but distinct from simpler racetam-class compounds.
Research interest centers on its proposed effects on high-affinity choline uptake (HACU) in cholinergic neuronal models, including reported activity in HACU-impaired model systems. Research applications include cholinergic transporter pharmacology, HACU restoration studies, and structure-activity relationship research within the furoquinoline-acetamide compound series.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
3D Molecular Structure
Drag to rotate · scroll to zoom| Chemical Formula | C19H23N3O3 |
|---|---|
| Synonyms | Coluracetam 135463-81-9, N-(2,3-dimethyl-5,6,7,8-tetrahydrofuran[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide, MKC-231 |
| Molar Mass | 341.4 g/mol |
| CAS Number | 135463-81-9 |
| PubChem CID | 214346 |
| Total Compound Content | 1 gram |
| Shelf Life | 36 months |
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
How does coluracetam's effect on HACU in impaired model systems differ from its activity under baseline conditions?
Research distinguishes coluracetam's reported capacity to restore choline uptake function in experimentally HACU-impaired cell or synaptosome models from simple potentiation of normally functioning choline transport. This distinction is investigated using paradigms that first chemically or genetically impair HACU activity (establishing a reduced-function baseline) before assessing whether coluracetam exposure restores uptake kinetics toward normal-function levels, a different experimental question than measuring potentiation above an already-normal baseline.
What structural features distinguish coluracetam from classical pyrrolidinone-only racetam compounds?
Coluracetam retains a 2-oxopyrrolidinone acetamide substituent characteristic of the racetam family but appends this to a tetrahydrofuroquinoline ring system, a considerably more complex polycyclic structure than the simple substituents found on piracetam, oxiracetam, or pramiracetam. This structural distinction is relevant to structure-activity relationship research examining whether choline-uptake-modulating activity depends primarily on the shared pyrrolidinone-acetamide moiety or is influenced by the broader molecular scaffold to which it is attached.
What assay formats quantify coluracetam's effects on the high-affinity choline transporter?
Radiolabeled choline uptake assays in synaptosome preparations or in cell lines expressing the high-affinity choline transporter (CHT1) are the standard quantitative method, allowing determination of uptake kinetic parameters (Km, Vmax) under coluracetam exposure relative to vehicle control. These assays are often run in parallel with HACU-impairment paradigms (e.g. using a choline transport inhibitor reference compound) to specifically test coluracetam's restorative versus potentiating activity profile.
